AUTO1 GROUP SE/ DE000A2LQ884 /
2024-05-06 7:51:42 PM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
5.4800USD | - | 9,000 Turnover: 49,320 |
-Bid Size: - | -Ask Size: - | 1.32 bill.USD | - | - |
GlobeNewswire
2:28 PM
RHR International Partners with SHL to Bring Data Analytics to its Leadership Assessment Solutions
GlobeNewswire
2:15 PM
Hip-Hop Duo Flyana Boss Joins Musicians On Call & Men’s Wearhouse in Making Prom Memories With Pedia...
GlobeNewswire
2:15 PM
Claritas HealthTech Extends Claritas iPET™ capability with iPETcertum™ for Automated Lesion Detectio...
GlobeNewswire
2:15 PM
Imperial Petroleum Inc. Reports First Quarter 2024 Financial and Operating Results
GlobeNewswire
2:05 PM
LED Lighting and EV Charging Solutions Provider Orion Previews FY 2024 Results in Anticipation of it...
GlobeNewswire
2:05 PM
MatrixCare Joins Health Gorilla’s Qualified Health Information Network (QHIN) to Enhance Patient Dat...
GlobeNewswire
2:05 PM
NKGen Biotech Announces Upcoming Presentation on Autologous NK Cell Therapy at the 5th International...
GlobeNewswire
2:03 PM
Meltwater Integrates Influencer Marketing Analytics, Workflows Within Social Suite, in an Industry F...
GlobeNewswire
2:01 PM
Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)
GlobeNewswire
2:01 PM
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Po...
GlobeNewswire
2:00 PM
Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company...
GlobeNewswire
2:00 PM
Allegro MicroSystems to Present at TD Cowen’s Technology, Media & Telecom Conference on May 29
GlobeNewswire
2:00 PM
Oragenics, Inc. Prepares Intranasal Pharmaceutical, ONP-002, for Phase II Concussion Trial
GlobeNewswire
2:00 PM
Akari Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights